Introduction {#s1}
============

*Vibrio cholerae* is a human pathogen that causes cholera, a severe acute watery diarrhea. There are more than 200 *V. cholerae* serogroups, however only O1 and O139 are responsible for most epidemics and pandemics of cholera. Serogroup O139 is restricted to some parts of Asia but serogroup O1, classified as El Tor and classical biotypes, was found worldwide [@pntd.0002049-Salim1], [@pntd.0002049-Safa1]. The classical biotype was responsible for severe clinical manifestation but the conventionally less virulent El Tor is better adapted to the environment [@pntd.0002049-Sack1].

The major virulence factors are the cholera toxin (CT) encoded by the *ctxAB* operon on the lysogenic bacteriophage CTXΦ [@pntd.0002049-Waldor1], and the toxin-coregulated pilus (TCP) encoded by the VPI-I island, an essential factor for the colonization and also receptor for the CTXΦ [@pntd.0002049-Karaolis1]. Classical and El Tor biotypes can be distinguished by several genetic markers, such as *rstR*, *tcpA*, *ctxB* genes, the Vibrio seventh pandemic island-I (VSP-I) and VSP-II, and by the number of genes in the repeat toxin region (RTX) [@pntd.0002049-Safa1], [@pntd.0002049-Kumar1].

Recently, *V. cholerae* strains have been identified showing markers of both classical and El Tor biotypes. These strains were assigned as hybrid biotype, altered or El Tor variants presenting a typical El Tor phenotype but with non-El Tor *ctxB* allele [@pntd.0002049-Safa1]. In contrast to *V. cholerae* from the beginning of 7^th^ cholera pandemic, these atypical biotype strains are frequently multidrug resistant. Changes in the antibiotic resistance profiles of *V. cholerae* are associated with mutations in housekeeping genes as well as acquisition of Integrative Conjugative Elements (ICEs) and other mobile elements [@pntd.0002049-Ceccarelli1], [@pntd.0002049-Quilici1].

Africa is endemic for cholera and frequently affected by outbreaks and epidemics, but there are few molecular epidemiology studies characterizing the determinants of these episodes. Nigeria is in one of the three major current cholera foci in the world [@pntd.0002049-Piarroux1]. In 2009, outbreaks began in Nigeria and other countries at the Lake Chad basin [@pntd.0002049-Quilici1] with the first reports coming from Maiduguri, a city in the far north-east of the country. Subsequently, outbreaks were reported from distant locales in Northern and Western Nigeria, and in 2010 a severe outbreak, which started in the Northern Nigeria spreading through the country, was projected as the worst outbreak in Nigeria since 1991. This outbreak was marked with highest case-fatality [@pntd.0002049-Adagbada1], what could be in part due to changes in *V. cholerae* infectivity even though the organism remains largely unknown. It can be hypothesized that an index strain has been disseminated cross-country by human travel.

Here, we performed a comprehensive characterization of representative *V. cholerae* strains from sequential outbreaks in Nigeria (Maiduguri/2009, Bauchi/2010 and Ile Ife/2010) by means of biotyping, multilocus sequence analysis (MLSA), pulsed-field gel electrophoresis (PFGE), as well as detection and sequencing of virulence related genes and genetic determinants of antimicrobial resistance. Our results show that recent cholera outbreaks in Nigeria are driven by atypical El Tor strains and we reported the presence of a non-O1/non-O139 lineage. The atypical El Tor strains showed one unique combination of virulence factor alleles and antimicrobial resistance to sulphonamides, trimethoprim/sulfamethoxazole, streptomycin, nalidixic acid and reduced susceptibility to ciprofloxacin and chloramphenicol.

Materials and Methods {#s2}
=====================

Bacterial strains {#s2a}
-----------------

Twenty *V. cholerae* strains (15 O1 and five non-O1/non-O139 strains) isolated from outbreaks in Nigeria and reference strains were analyzed ([Table 1](#pntd-0002049-t001){ref-type="table"}). We included in our analysis three isolates that originated from Nigeria in the beginning of the seventh pandemic (1970\'s), 16 isolates from three recent cholera outbreaks and one strain isolated from a water sample. *V. cholerae* isolates were identified and confirmed by standard culture methods at isolation during the epidemics and again prior to molecular characterization, and their serogroups and biotypes were identified by biochemical and molecular methods [@pntd.0002049-Hoshino1].

10.1371/journal.pntd.0002049.t001

###### Genetic and phenotypic characteristics of *V. cholerae* from Nigeria.

![](pntd.0002049.t001){#pntd-0002049-t001-1}

  Strain                                       Serogroup (biotype)   Place of isolation   Year of isolation   Virulence related genes and biotypes   Related to antibiotic resistance                                                                    
  ------------------------------------------- --------------------- -------------------- ------------------- -------------------------------------- ---------------------------------- ---- ---------- ---- ---- ---- ---- ---------- ---------- ------- -----
  Reference[¥](#nt103){ref-type="table-fn"}                                                                                                                                                                                                              
  N16961                                           O1 (El Tor)           Bangladesh             1975                           \+                                   \+                  3       ET      ET   \-   \-   −     Ser83      Ser85      ND     ND
  CIRS101                                          O1 (El Tor)       Dhaka, Bangladesh          2002                           −                                    \+                  1    ET^CIRS^   ET   \-   \-   \+   Ser83Ile    Ser85      ND     ND
  MO10                                                O139             Madras, India            1992                           −                                    \+                  3       ET      ET   \-   \-   \+    Ser83      Ser85      ND     ND
  O395                                           O1 (Classical)            India                1965                           −                                    −                   1       CL      CL   \-   \-   −     Ser83      Ser85      ND     ND
  RC27                                           O1 (Classical)          Indonesia              1991                           −                                    −                   1       CL      CL   \-   \-   −     Ser83      Ser85      ND     ND
  Nigeria strains                                                                                                                                                                                                                                        
  VC79                                                 O1                 Nigeria               1971                           \+                                   \+                  \-      \-      ET   \-   \-   −     Ser83      Ser85     0.008   ND
  VC111                                                O1                 Nigeria               1972                           \+                                   \+                  3       ET      ET   \-   \-   −     Ser83      Ser85     0.008   ND
  VC869                                                O1                 Nigeria               1971                           \+                                   \+                  3       ET      ET   \-   \-   −     Ser83      Ser85     0.008   ND
  VC832                                                O1                Maiduguri              2009                           −                                    \+                  7    ET^CIRS^   ET   \-   \-   \+   Ser83Ile   Ser85Leu   0.380   8.0
  VC841                                                O1                Maiduguri              2009                           −                                    \+                  7    ET^CIRS^   ET   \-   \-   \+   Ser83Ile   Ser85Leu   0.250   8.0
  VC833                                                O1                 Ile Ife               2010                           −                                    \+                  7    ET^CIRS^   ET   \-   \-   \+   Ser83Ile   Ser85Leu   0.250   6.0
  VC834                                                O1                 Ile Ife               2010                           −                                    \+                  7    ET^CIRS^   ET   \-   \-   \+   Ser83Ile   Ser85Leu   0.250   6.0
  VC835                                                O1                 Ile Ife               2010                           −                                    \+                  7    ET^CIRS^   ET   \-   \-   \+   Ser83Ile   Ser85Leu   0.380   6.0
  VC991                                                O1                 Ile Ife               2010                           −                                    \+                  7    ET^CIRS^   ET   \-   \-   \+   Ser83Ile   Ser85Leu   0.380   6.0
  VC997                                                O1                 Ile Ife               2010                           −                                    \+                  7    ET^CIRS^   ET   \-   \-   \+   Ser83Ile   Ser85Leu   0.380   6.0
  VC1001                                               O1                 Ile Ife               2010                           −                                    \+                  7    ET^CIRS^   ET   \-   \-   \+   Ser83Ile   Ser85Leu   0.380   6.0
  VC1007                                               O1                 Ile Ife               2010                           −                                    \+                  7    ET^CIRS^   ET   \-   \-   \+   Ser83Ile   Ser85Leu   0.380   8.0
  VC836                                                O1                  Bauchi               2010                           −                                    \+                  7    ET^CIRS^   ET   \-   \-   \+   Ser83Ile   Ser85Leu   0.380   8.0
  VC996                                              Non-O1                Bauchi               2010                           −                                    −                   \-      \-      \-   \-   \-   −     Ser83      Ser85     0.023   0.5
  VC998                                              Non-O1                Bauchi               2010                           −                                    −                   \-      \-      \-   \-   \-   −     Ser83      Ser85     0.008   0.5
  VC999                                                O1                  Bauchi               2010                           −                                    \+                  7    ET^CIRS^   ET   \-   \-   \+   Ser83Ile   Ser85Leu   0.380   6.0
  VC1004                                               O1                  Bauchi               2010                           −                                    \+                  7    ET^CIRS^   ET   \-   \-   \+   Ser83Ile   Ser85Leu   0.500   6.0
  VC1006                                             Non-O1                Bauchi               2010                           −                                    −                   \-      \-      \-   \-   \-   −     Ser83      Ser85     0.012   0.5
  VC1009                                             Non-O1                Bauchi               2010                           −                                    −                   \-      \-      \-   \-   \-   −     Ser83      Ser85     0.008   0.5
  VC1005[§](#nt104){ref-type="table-fn"}             Non-O1               Ile Ife               2010                           −                                    −                   \-      \-      \-   \-   \-   −    Ser83Ile   Ser85Leu   0.250   ND

CL, classical; ET, El Tor; CIP, ciprofloxacin; CM, Chloramphenicol; ND, not determined;

, *ctxB* genotype [@pntd.0002049-Marin1];

, The genetic characteristics were determined by *in silico* analysis;

, VC1005 is an environmental isolate.

PCR amplification and sequencing {#s2b}
--------------------------------

PCR were performed targeting the genetic elements and regions associated with *V. cholerae* virulence, resistance and biotype. Virulence: VSP-II (VC0511, VC0513), VPI-I (*tcpA*), CTXΦ (*ctxB*), heat stable enterotoxin (NAG-ST), type three secretion system (T3SS), type VI secretion system (T6SS), enterotoxigenic hemolysin (*hlyA*) and RTX toxin (*rtxA*). Resistance: *IntI*1, *IntI*2 integrases and variable regions from class 1 and 2 integrons and the 3′ conserved sequence from class 1 integron, SXT element-integrase gene and associated SXT resistance genes (*floR*, *sul2*, *dfrA1* and *strAB*) and genes related to quinolone resistance (*gyrA*, *gyrB*, *parC* and *parE*). Biotype-specific repeat sequence transcriptional regulator (*rstR*), *ctxB* alleles and *rfb* gene specific for O1 serogroup 1 were also amplified. The nucleotide sequences of primers employed are listed in [Table 2](#pntd-0002049-t002){ref-type="table"}.

10.1371/journal.pntd.0002049.t002

###### PCR primers used in this study.

![](pntd.0002049.t002){#pntd-0002049-t002-2}

  Primer                          Sequence (5′-3′)                 Reference
  -------------------------- --------------------------- -----------------------------
  Housekeeping gene                                      
  recA-01-F                     TGARAARCARTTYGGTAAAGG      [@pntd.0002049-Thompson2]
  recA-02-R                      TCRCCNTTRTAGCTRTACC     
  pyrH-04-F                     ATGASNACBAAYCCWAAACC       [@pntd.0002049-Thompson2]
  pyrH-02-R                      GTRAABGCNGMYARRTCCA     
  mdh-1                          ATGAAAGTCGCTGTTATT         [@pntd.0002049-OShea1]
  mdh-2                          GTATCTAACATGCCATCC      
  Biotype related genes                                  
  Serogroup O1                                           
   O1-F                          GTTTCACTGAACAGATGGG     
   O1-R                          GGTCATCTGTAAGTACAAC       [@pntd.0002049-Hoshino1]
  rstR                                                   
   rstRclaF                     TTTGCTACTTCTTCTTGGTT     
   rstRETF                      TGAGCATAAGCTCTTGATTT     
   rstAR                         CCGTGAAAGTCATCAACG          [@pntd.0002049-Lee1]
  Virulence gene primers                                 
  VSP-II                                                 
   VC0511F1                      CTTGCTGCGTACTTAGCA      
   VC0511R1                      AGTAGCATCGCTCTCGTA         [@pntd.0002049-Nusrin1]
   VC0513F1                     CTGAGGTGTTATATGTTTCG     
   VC0513R1                     TCAAATTTCCTGACAGTTCC        [@pntd.0002049-Nusrin1]
  VPI-I                                                  
   TCPA1                      CACGATAAGAAAACCGGTCAAGAG   
   TCPA2                      ACCAAATGCAACGCCGAATGGAGC     [@pntd.0002049-Keasler1]
  CTX Φ                                                  
   CT8                          GCAGTCAGGTGGTCTTATTGC    
   CT10                         TCCAGATATGCAATCCTCAG       [@pntd.0002049-Thompson1]
  NAG-ST                                                 
   ST-1                          GAGAAACCTATTCATTGCA     
   ST-2                           GCAAGCTGGATTGCAAC        [@pntd.0002049-Vicente1]
  T3SS                                                   
   vcsV2-F                      GGCTCACCAGCTGTTATGGT     
   vcsV2-R                      CGTATTGCACAAGTAGCCGC              This study
  T6SS                                                   
   vasH-F                       TGTTGATGGGCGAGAGTCAC     
   vasH-R                       ACGTGTGTGGCAGATACCAG              This study
  HlyA                                                   
   VC0489F                      AGATCAACTACGATCAAGCC     
   VC0489R                      AGAGGTTGCTATGCTTTCTAC       [@pntd.0002049-OShea1]
  RTX                                                    
   rtxA1                         GCGATTCTCAAAGAGATGC     
   rtxA2                         CACTCATTCCGATAACCAC        [@pntd.0002049-OShea1]
  Resistance gene primers                                
  Integron related primers                               
   INT1 F                       AAAACCGCCACTGCGCCGTTA    
   INT1 R                       GAAGACGGCTGCACTGAACG       [@pntd.0002049-Fonseca1]
   INT2 F                       GCGTTTTATGTCTAACAGTCC    
   INT2 R                        AAGTAGCATCAGTCCATCC       [@pntd.0002049-Opintan1]
  SXT integrase                                          
   SXTF                         TCGGGTATCGCCCAAGGGCA     
   SXTR                         GCGAAGATCATGCATAGACC      [@pntd.0002049-Bhanumathi1]
  ICE\'s related genes                                   
   dfrA1 F                       CGTGACAGGTTTGCGAATC     
   dfrA1 R                      ATGGAGTGCCAAAGGTGAAC              This study
   strB F                       CGTTGCTCCTCTTCTCCATC     
   sul2 R                       CGTCAACATAACCTCGGACA              This study
   FloR F                       GTGATTTTTGGTCCGCTCTC     
   FloR R                       TCGGTAGGATGAAGGTGAGG              This study
  Quinolone resistance                                   
   gyrA_vF                      AATGTGCTGGGCAACGACTGG    
   gyrA_vR                      GTGCGCGATTTTCGACATACG      [@pntd.0002049-Baranwal1]
   gyrB_vF                      GGAAATGACTCGCCGTAAAGG    
   gyrB_vR                    GTTGTGATAACGCAGTTTATCTGGG    [@pntd.0002049-Baranwal1]
   parC_vF                      GTCTGAGTTGGGTCTCTCGGC    
   parC_vR                     AGAATCTCGGCAAACTTTGACAG     [@pntd.0002049-Baranwal1]
   parE_vF                      ATGCGTGCCAGCAAGAAAGTG    
   parE_vR                     TTATCGCTGTCAGGGTCAATCC      [@pntd.0002049-Baranwal1]
   oqxA_F                         CTCGGCGCGATGATGCT      
   oqxA_R                       CCACTCTTCACGGGAGACGA         [@pntd.0002049-Kim2]
   qepA_F                       GCAGGTCCAGCAGCGGGTAG     
   qepA_R                       CTTCCTGCCCGAGTATCGTG         [@pntd.0002049-Liu1]
   qnrA_F                       TTCAGCAAGAGGATTTCTCA     
   qnrA_R                       GGCAGCACTATTACTCCCAA          [@pntd.0002049-Wu1]
   qnrB_F                       CCTGAGCGGCACTGAATTTAT    
   qnrB_R                       GTTTGCTGCTCGCCAGTCGA          [@pntd.0002049-Wu1]
   qnrS_F                       CAATCATACATATCGGCACC     
   qnrS_R                       TCAGGATAAACAACAATACCC         [@pntd.0002049-Wu1]
   qnrVC_F                     AATTTTAAGCGCTCAAACCTCCG   
   qnrVC_R                     TCCTGTTGCCACGAGCATATTTT       [@pntd.0002049-Kim3]
   aac(6′)-lb-cr \_F           TTGCGATGCTCTATGAGTGGCTA   
   aac(6′)-lb-cr \_R            CTCGAATGCCTGGCGTGTTT         [@pntd.0002049-Park1]

MLSA {#s2c}
----

Amplification and sequencing of the *pyrH*, *recA* and *mdh* housekeeping genes were performed as described previously ([Table 2](#pntd-0002049-t002){ref-type="table"}). Sequence alignments and phylogenetic analyses were conducted using MEGA5 [@pntd.0002049-Tamura1], based on the minimum evolution method using concatenated sequences. Distance estimations were obtained by Kimura two-parameter model. Two thousand bootstrap replicates were performed.

Pulsed-Field Gel Electrophoresis {#s2d}
--------------------------------

DNA macrorestriction profile was obtained using *NotI* enzyme according to procedures described elsewhere [@pntd.0002049-Fonseca1]. The PFGE dendrogram was constructed using BioNumerics software (Applied Maths, Belgium). The similarity was determined by Dice coefficient and cluster analysis was carried out with the unweighted-pair group method using average linkages (UPGMA).

Disk diffusion susceptibility testing and Etest {#s2e}
-----------------------------------------------

Antibiotic susceptibility testing was performed by the disk diffusion method, with Muller-Hinton Agar (Oxoid, Basingstoke, UK), according to Clinical and Laboratory Standards Institute (CLSI, 2010) standards. Strains were tested for resistance to: Nalidixic acid, Ampicillin, Cephalothin, Cefpirom, Cefoxitin, Cefuroxime sodium, Ciprofloxacin, Chloramphenicol, Erythromycin, Spectinomycin, Compound sulphonamides, Streptomycin, Sulphamethoxazole, Sulphamethoxazole-Trimethopim, Trimethopim and Tetracycline. Minimum Inhibitory Concentrations (MICs) for Ciprofloxacin and Chloramphenicol were determined with the E-test (bioMerieux, Marcy l\'Etoile, France).

Results {#s3}
=======

*V. cholerae* genotyping {#s3a}
------------------------

We determined the genetic relationships among *V. cholerae* strains consisting of Nigeria strains from 2009/2010 and 1971/1972, one environmental isolate (2010) and well-characterized reference strains. A MLSA tree based on concatenated sequence of *recA* (666 bp), *pyrH* (456 bp) and *mdh* (591 bp) gene fragments were constructed.

The MLSA tree showed three major clusters: (i) O1 El Tor, O139 (MO10 strain) and the O1 clinical Nigeria strains, including the ones from the 1970s ([Figure 1](#pntd-0002049-g001){ref-type="fig"}), (ii) O1 classical (O395 and RC27) and (iii) non-O1/non-O139 Nigeria strains. The average pairwise difference for the *V. cholerae* concatenated sequences was 1.5%. The divergence between the El Tor/O139 cluster and the classical cluster was 1.2% while the El Tor/O139 cluster and non-O1 cluster was 1.9%. This grouping was also revealed by macrorestriction analysis using representative strains of the MLSA analysis ([Figure 2](#pntd-0002049-g002){ref-type="fig"}. VC04 and VC200 strains were used as representative classical strains of the 6^th^ pandemic and El Tor VC121 of the beginning of the 7^th^ pandemic from India. The PFGE profiles showed that the Nigeria strains from the beginning of the 7^th^ pandemic (VC869, VC111, VC79) and the recent strains (VC1004, VC832 and VC835) are genetically related and shared a profile with El Tor VC121. The non-O1 strains (VC1006 and VC998) shared a unique profile distinct from the O1 strains.

![Genetic relatedness of Nigeria *V. cholerae* strains.\
The epidemic O1 Nigeria strains are within the El Tor/139 cluster and the Non-O1/Non-O139 strains characterized a distinct cluster. This Minimum Evolution tree was constructed based on Kimura-two-parameter method using the concatenated nucleotide sequences of *rec*A, *pyr*H and *mdh* gene fragments. Two thousand bootstrap replicates were performed; bootstrap values are given at the nodes. *Vibrio mimicus* MB451strain was used as outgroup.](pntd.0002049.g001){#pntd-0002049-g001}

![Dendrogram of PFGE patterns of representative *V. cholerae* O1 and Non-O1/Non-O139 strains.\
The similarity was determined using the Dice coefficient, and cluster analysis was performed using the UPGMA. The right panel shows the presence (dark box) and absence (light box) of genomic traits. VC04 and VC200 belong to the classical lineage; VC121 is an India strain from the beginning of the 7^th^ cholera pandemic.](pntd.0002049.g002){#pntd-0002049-g002}

Biotyping and virulence gene typing {#s3b}
-----------------------------------

PCR-verified serogroup analysis demonstrated that 15 of the 20 strains studied, belonged to serogroup O1 and five were non-O1 isolates ([Table 1](#pntd-0002049-t001){ref-type="table"}). *V. cholerae* O1 strains are classified into El Tor, classical and atypical El Tor [@pntd.0002049-Safa1] based on *tcpA* (toxin co-regulated pilin A), *ctxB* (cholera toxin B), *rstR* (repeat sequence transcriptional regulator), as well as variations in VSP-II (Vibrio seventh pandemic island II). The VSP-II gene cluster characterizes the El Tor strains, and comprises a region of ∼24 ORFs. In this study, *V. cholerae* O1 strains were genotyped based on sequence information of *rstR*, *ctxB*, *tcpA*, VSP-II regions (locus VC0511 and VC0513).

We screened for the presence of two loci of the VSP-II, VC0511 and VC0513, which are considered the most variable loci in the VSP-II island [@pntd.0002049-Nusrin1], [@pntd.0002049-Taviani1]. The Nigeria strains from 1970\'s and the prototypical N16961, were positive for VC0511 and VC0513 loci, while the more recently recovered 2009/10 O1 El Tor Nigeria isolates harbor only VC0513 ([Table 1](#pntd-0002049-t001){ref-type="table"}), indicating that these lineages carry a different version of VSP-II than earlier isolates. The current non-O1 Nigeria strains were negative for both, VC0511 and VC0513 loci.

The *ctxB* present in all Nigeria current O1 El Tor strains belong to the atypical genotype 7, characterized by the non conservative change His20Asn [@pntd.0002049-Marin1]. El Tor strains from the beginning of the 7^th^ pandemic in Nigeria, as worldwide, were characterized by the canonical El Tor *ctxB* genotype 3 and keep their own repressor *rstR* ^ElTor^ gene of the CTX prophage.

Concerning the *tcpA* alleles, there are *tcpA* ^ElTor^, *tcpA* ^classical^ and *tcpA* ^NonO1^ disseminated among *V. cholerae* strains. All current O1 Nigeria strains harbor *tcpA* ^CIRS^ allele ([Table 1](#pntd-0002049-t001){ref-type="table"}), recently described in the CIRS101 strain, a *V. cholerae* O1 El Tor from Bangladesh, 2002 [@pntd.0002049-Talkington1]. Based on these genotypes, the current epidemic *V. cholerae* O1 strains from Nigeria are classified as atypical El Tor biotype.

Although, the current non-O1/non-O139 Nigeria strains were negative for *rstR*, *ctxB*, *tcpA*, VSP-II regions (locus VC0511 and VC0513) as well NAG-ST and T3SS (*vcsV2* gene), they are positive for T6SS (*vasH* gene), *hlyA* and *rtxA* genes, all virulence associated factors involved in diarrheiogenic property [@pntd.0002049-Chen1]--[@pntd.0002049-Chatterjee1]. Therefore, a non-O1/non-O139 lineage harboring a set of virulence determinants could be associated with a cholera-like diarrhea [@pntd.0002049-Dalsgaard1].

Characterization of elements associated with antibiotic resistance {#s3c}
------------------------------------------------------------------

Antibiotic multidrug resistance is becoming increasingly common among the atypical *V. cholerae* strains, mostly associated with acquisition of genes and/or modification in the antibiotic target genes [@pntd.0002049-Okeke1]. According to our results, the current O1 Nigeria strains were resistant to streptomycin, trimethoprim and sulfonamides. In *V. cholerae*, these resistances, are frequently associated with class 1 and 2 integrons [@pntd.0002049-Opintan1] and SXT element, which is a *V. cholerae*-derived ICE (integrating and conjugative element) [@pntd.0002049-Waldor2]. Thus, we investigated the presence of these elements in the Nigeria strains. All the current O1 strains harbor an ICE element, determined by the presence of the SXT integrase gene, contrasting with non-O1 and the O1 from the 1970\'s ([Table 1](#pntd-0002049-t001){ref-type="table"}). No evidence was found for the presence of class 1 and 2 integrons (which we sought by PCR for *intI*1 and *intI*2, respectively. [Table 1](#pntd-0002049-t001){ref-type="table"}). We performed PCR targeting ICE associated genes *floR*, *sul2*, *dfrA1*, and *strAB*, associated with chloramphenicol, sulfamethozaxole, trimethoprim and streptomycin resistance, respectively [@pntd.0002049-Ceccarelli1], [@pntd.0002049-SjlundKarlsson1]. All these genes were identified, explaining the resistance profile, including reduced susceptibility to chloramphenicol, of the current O1 strains.

Majority of the 2009/10 Nigeria O1 strains showed reduced susceptibility to ciprofloxacin ([Table 1](#pntd-0002049-t001){ref-type="table"}) as well as resistance to nalidixic acid. Quinolone resistance has been attributed to mutations in *gyrA* (Ser83Ile) and in *parC* (Ser85Leu) [@pntd.0002049-SjlundKarlsson1], [@pntd.0002049-Kim1] and these alleles were found in these strains. We additionally screened the 2009/10 isolates for horizontally transmitted quinolone-resistance genes *qnrA*, *qnrB*, *qnrS*, *qnrVC*, *qepA*, *oqxAB* and *aac(6′)-Ib-cr*. The isolates were all negative for all of these targets. None of these resistance phenotypes or genotypes detected in the 2009/10 isolates were found in strains isolated in Nigeria during the1970\'s. Additionally, resistance phenotype and genes were not seen in the 2009/10 non-O1/non-O139 isolates, with the exception of the environmental non-O1/non-O139 VC1005 strain, which showed resistance to nalidixic acid attributable to mutations in *gyrA* and *parC* ([Table 1](#pntd-0002049-t001){ref-type="table"}).

Discussion {#s4}
==========

Since 1995 and over a period of more than a decade the canonical El Tor has been replaced in Kolkata, India by atypical El Tor. They were originally described in South Asia [@pntd.0002049-Safa1], [@pntd.0002049-Ang1], [@pntd.0002049-Nair1] but recent reports have shown their spread to all continents, reaching even Mexico [@pntd.0002049-Alam1] and Haiti [@pntd.0002049-SjlundKarlsson1]. Based only on *ctxB* genotyping, atypical El Tor have already been reported in some African countries, where cholera has become a serious public health threat in recent years [@pntd.0002049-Ceccarelli1], [@pntd.0002049-Quilici1], [@pntd.0002049-Mintz1]--[@pntd.0002049-Thompson1].

Despite the great impact from cholera, few investigators focused on the molecular epidemiology of *V. cholerae* in West Africa. A recent genomic survey of 154 isolates worldwide did not include any isolates from West Africa [@pntd.0002049-Mutreja1]. Due to the plasticity of *V. cholerae* resulting in the constant emergence of variants, surveillance and characterization of outbreak strains, and their antibiotic resistance determinants, is essential to defining the complex scenario of cholera in this continent as well as worldwide. Recently, it was shown that different *V. cholerae* O1 lineages were responsible for cholera outbreaks in Ghana [@pntd.0002049-Thompson1]. Here, we provide evidence that different *V. cholerae* lineages are driving cholera outbreaks in Nigeria.

Molecular typing of 20 *V. cholerae* strains from Nigeria, allowed us to identify atypical O1 strains as well as a non-O1/non-O139 lineage. To date, there are only two studies performing molecular characterization of *V. cholerae* strains causing cholera in Nigeria and very few microbiological outbreak investigations [@pntd.0002049-Quilici1], [@pntd.0002049-Talkington1]. Both molecular studies focused on the allelic characterization of the two major virulence genes and one of them addressed also the quinolone resistance determinants. Talkington *et al*, who analyzed two 2008 isolates from Nigeria, reported two profiles: *ctxB*-1/*tcpA* ^ElTor^/*rstR* ^ElTor^ and *ctxB*-1/*tcpA* ^CIRS^/*rstR* ^ElTor^ [@pntd.0002049-Talkington1]. Quilici and collaborators analyzing ten strains from 2009 showed a unique allelic profile: *ctxB*-7/*tcpA* ^ElTor^/*rstR* ^ElTor^ [@pntd.0002049-Quilici1]. They reported that these isolates were identical to nine isolates from neighboring Cameroon, which also borders the Lake Chad basin. These isolates are temporally and geographically proximal to the 2009 Maiduguri outbreak from which we obtained isolates VC832 and VC841 for our study. In our study, considering these set of genes, the 12 *V. cholerae* O1 strains, from 2009/2010 cholera outbreaks including the 2009 Maiduguri outbreak, presented a new combination of alleles: *ctxB*-7/*tcpA* ^CIRS^/*rstR* ^ElTor^. Interestingly, a strain carrying same combination of *ctxB*-7 and *tcpA* ^CIRS^ alleles, as the profile identified in this work, was characterized causing cholera in Cameroon and Haiti in 2010 [@pntd.0002049-Talkington1]. Strains from the 2010 Bauchi outbreak in North Central Nigeria and the 2010 Ile-Ife outbreak, both evaluated in this study, were also predominantly of the *ctxB*-7 and *tcpA* ^CIRS^ genotype. Therefore it is likely that these four genotypes were co-circulating in the Chad basin at that time [@pntd.0002049-Quilici1].

In the Quilici *et al* study [@pntd.0002049-Quilici1], *V. cholerae* strains showed intermediate susceptibility to chloramphenicol, reduced susceptibility to ciprofloxacin and resistance to trimethoprim/sulfamethoxazole, sulfonamides and nalidixic acid, and the *gyrA* ^Ser83Ile^/*parC* ^Ser85Leu^ alleles related to quinolone resistance. This same resistance phenotypic and genotypic profile was found in isolates from all three outbreaks represented in this study ([Table 1](#pntd-0002049-t001){ref-type="table"}). Moreover, we found that the 2009/10 O1 Nigeria strains carried *sul2*, *dfrA1* and *floR* genes, conferring resistance to sulfonamides, trimethoprim, and intermediate susceptibility to chloramphenicol, respectively, and *strA/B*, which confers to streptomycin resistance. These genes have been associated with integrative and conjugative elements (ICEs) and the 2009/10 O1 Nigeria strains were positive for the SXT integrase, indicating that these strains harbor an ICE. ICEs have been identified in *V. cholerae* strains from Ghana [@pntd.0002049-Opintan1], Kenya [@pntd.0002049-Mutreja1], Mozambique [@pntd.0002049-Taviani2] and Angola [@pntd.0002049-Ceccarelli1]. In contrast to the 2009/10 isolates, the Nigeria strains from the beginning of the 7^th^ cholera pandemic had the canonical El Tor allelic profile *ctxB*-3/*tcpA* ^ElTor^/*gyrA* ^Ser83^/*parC* ^Ser85^ and lacked most of the resistance genes.

Interestingly, as reported elsewhere [@pntd.0002049-Hasan1], we found that a lineage of *V. cholerae* non-O1/non-O139, lacking the major virulence determinants and the resistance phenotype described above, but harboring a set of virulence associated genes was co-circulating with atypical El Tor strains being recovered from patients with cholera-like disease in Bauchi, Nigeria in 2010. This outbreak followed the Maiduguri outbreak and were accompanied by a slightly improved public engagement response. It is probable that individuals with cholera-like disease are more likely to present to health facilities when they have received information about an on-going cholera outbreak. Our findings suggest that non-O1/non-O139 *V. cholerae* may be important causes of endemic diarrheal disease and outbreaks. Recovery of a similar strain from water tested in Ile-Ife supports this possibility.

Population structure of clinical *V. cholerae* strains can be influenced by epidemiological factors like transmission dynamics, clonal expansion during epidemics, human travel, and selective pressure from antimicrobial drugs. The data in our study showed that recent outbreaks in Nigeria are caused by multidrug resistant atypical El Tor O1 strains, which are reportedly highly virulent [@pntd.0002049-Quilici1], [@pntd.0002049-GhoshBanerjee1]--[@pntd.0002049-Siddique1], a common worrisome trend in the current cholera outbreaks around the world. The data suggest that guidelines for managing and containing cholera outbreaks in Nigeria (which include, in addition to rehydration, using the antimicrobials trimethoprim, and more recently ciprofloxacin) need to be urgently revised. The data also show that *V. cholerae* non-O1/non-O139 strains were involved in outbreaks in Nigeria suggesting that interventions to control epidemic cholera such as improvements in water supplies and sanitation, as well as vaccination, may result in broad gains.
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